PRELUDE CAPITAL MANAGEMENT, LLC - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 39 filers reported holding BIOTECH ACQUISITION COMPANY in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q3 2022$1,000
-91.7%
18,731
+3.2%
0.00%
Q4 2021$12,000
+9.1%
18,154
+13.4%
0.00%
Q3 2021$11,000
-21.4%
16,0040.0%0.00%
Q2 2021$14,00016,0040.00%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q2 2021
NameSharesValueWeighting ↓
Kingstown Capital 300,000$18,0000.06%
Radcliffe Capital Management, L.P. 202,950$2,014,0000.05%
RAMIUS ADVISORS LLC 567,986$34,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 63,832$633,0000.02%
MARSHALL WACE, LLP 575,000$5,709,0000.01%
Telemetry Investments, L.L.C. 153,694$9,0000.01%
Q Global Advisors, LLC 300,000$15,0000.01%
LMR Partners LLP 50,000$496,0000.01%
Segantii Capital Management Ltd 25,000$248,0000.01%
Corbin Capital Partners, L.P. 464,062$28,0000.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders